Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8)

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 885-890

  Yoshida, Makoto ^a   Kikukawa, Masanobu ^a   Hisa, Hiroaki ^a   Satoh, Susumu ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin II (3 8); Nitric oxide; Prostaglandins; Renal haemodynamics; Spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN II [3-8]; INDOMETACIN; LOSARTAN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYPERTENSION; KIDNEY BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0030003728     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15276.x     Document Type: Article

References (23)

1. AIKEN, J.W. & VANE, J.R. (1973). Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J. Pharmacol. Exp. Ther., 184, 678-687.
2. CHU, Z.M. & BEILIN, L.J. (1993). Nitric oxide-mediated changes in vascular reactivity in pregnancy in spontaneously hypertensive rats. Br. J. Pharmacol., 110, 1184-1188.
3. G-monotnethyl-L-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats. Am. J. Physiol., 262, R1137-R1144.
4. DONI, M.G., WHITTLE, B.J.R., PALMER, R.M.J. & MONCADA, S. (1988). Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur. J. Pharmacol., 151, 19-25.
5. FITZSIMONS, J.T. (1971). The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J. Physiol., 214, 295-303.
6. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1993). Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br. J. Pharmacol., 110, 159-162.
7. HABERL, R.L., DECKER, P.J. & EINHÄUPL, K.M. (1991). Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ. Res., 68, 1621-1627.
8. HALL, K.L., HANESWORTH, J.M., BALL, A.E., FELGENHAUER, G.P., HOSICK, H.L. & HARDING, J.W. (1993). Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul. Pept., 44, 225-232.
9. HANESWORTH, J.M., SARDINIA, M.F., KREBS, L.T., HALL, K.L. & HARDING, J.W. (1993). Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes. J. Pharmacol. Exp. Ther., 266, 1036-1042.
10. ITO, S., JOHNSON, C.S. & CARRETERO, O.A. (1991). Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J. Clin. Invest., 87, 1656-1663.
11. 2 interactions in spontaneously hypertensive rats. Hypertension, 22, 688-698.
12. KANNER, J., HAREL, S. & GRANIT, R. (1992). Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids, 27, 46-49.
13. MAROTTA, P., SAUTEBIN, L. & DI-ROSSA, M. (1992). Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol., 107, 640-641.
14. G-nitro-L-arginine, a nitric oxide synthase inhibitor. Biol. Pharm. Bull., 18, 496-500.
15. MILLER-WING, A.V., HANESWORTH, J.M., SARDINIA, M.F., HALL, K.L., WRIGHT, J.W., SPETH, R.C., GROVE, K.L. & HARDING, J.W. (1993). Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J. Pharmacol. Exp. Ther., 266, 1718-1726.
16. MISUMI, J., GONZALES, M.F., OGIHARA, T., CORVOL, P. & MENARD, J. (1983). Vascular effects and metabolism of angiotensins and their metabolites in the isolated-perfused rat kidney. Clin. Exp. Hypertens., A5, 1151-1162.
17. RUILOPE, L.M., LAHERA, V., RODICIO, J.L. & ROMERO, J.C. (1994). Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J. Hypertens., 12, 625-631.
18. SALOM, M.G., LAHERA, V. & ROMERO, J.C. (1991). Role of prostaglandins and endothelium-derived relaxing factor on the renal response to acetylcholine. Am. J. Physiol., 260, F145-F149.
19. SHEPHERD, J.T. & KATUŠIĆ, Z.S. (1991). Endothelium-derived vasoactive factors: I; Endothelium-dependent relaxation. Hypertension, 18, (Suppl. III), III-76-III-85.
20. STADLER, J., HARBRECHT, B.G., DI-SILVIO, M., CURRAN, R.D., JORDAN, M.L., SIMMONS, R.L. & BILLIAR, T.R. (1993). Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J. Leukoc. Biol., 53, 165-172.
21. SWANSON, G.N., HANESWORTH, J.M., SARDINIA, M.F., COLEMAN, J.K.M., WRIGHT, J.W., HALL, K.L., MILLER-WING, A.V., STOBB, J.W., COOK, V.I., HARDING, E.C. & HARDING, J.W. (1992). Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul. Pept., 40, 409-419.
22. UEHARA, Y., HIRAWA, N., KAWABATA, Y., SUZUKI, T., OHSHIMA, H., OKA, K., IKEDA, T., GOTO, A., TOYO-OKA, T., KIZUKI, K. & OMATA, M. (1994). Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension, 24, 770-778.
23. WRIGHT, J.W., JENSEN, L.L., ROBERTS, K.A., SARDINIA, M.F. & HARDING, J.W. (1989). Structure-function analyses of brain angiotensin control of pressor action in rats. Am. J. Physiol., 257, R1551-R1557.